Clopidogrel Resistance in Stroke Patients From Different Ethnicities
Clopidogrel Resistance in Stroke Patients From Different Ethnicities
Clopidogrel is an anti-platelet agent used to inhibit blood clots. Variation in response to
 clopidogrel has been reported among different population and may lead to reoccurring ischemic
 events. The aim of the present study is to evaluate the incidence of clopidogrel resistance
 in ischemic stroke patients from different ethnicities in Northern Israel and to find
 different strategies to overcome high platelet reactivity including clopidogrel dose
 adjustment or the choice of alternative agents. Quantification of platelet aggregation will
 be determined by vasodilator stimulated phosphoprotein (VASP) assay.
Inclusion Criteria:

 1. Ability to provide written informed consent and to be compliant with protocol
 assessments.

 2. Ages 18 and above inclusive

 3. Both genders eligible for the study

 4. Diagnosis of ischemic cerebrovascular event

 Exclusion Criteria:

 1. Pregnant patients will be excluded

 2. Ages below 18

 3. Patients not able to provide informed consent